These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 28944826)
1. MACC‑1 antibody target therapy suppresses growth and migration of non‑small cell lung cancer. Shi W; Song J; Wang W; Zhang Y; Zheng S Mol Med Rep; 2017 Nov; 16(5):7329-7336. PubMed ID: 28944826 [TBL] [Abstract][Full Text] [Related]
2. Effects of metastasis-associated in colon cancer 1 inhibition by small hairpin RNA on ovarian carcinoma OVCAR-3 cells. Zhang R; Shi H; Chen Z; Wu Q; Ren F; Huang H J Exp Clin Cancer Res; 2011 Sep; 30(1):83. PubMed ID: 21923915 [TBL] [Abstract][Full Text] [Related]
3. MiR-206 inhibits HGF-induced epithelial-mesenchymal transition and angiogenesis in non-small cell lung cancer via c-Met /PI3k/Akt/mTOR pathway. Chen QY; Jiao DM; Wu YQ; Chen J; Wang J; Tang XL; Mou H; Hu HZ; Song J; Yan J; Wu LJ; Chen J; Wang Z Oncotarget; 2016 Apr; 7(14):18247-61. PubMed ID: 26919096 [TBL] [Abstract][Full Text] [Related]
4. Chimeric antibody targeting SRPK-1 in the treatment of non-small cell lung cancer by inhibiting growth, migration and invasion. Wu F; Li J; Du X; Zhang W; Lei P; Zhang Q Mol Med Rep; 2017 Aug; 16(2):2121-2127. PubMed ID: 28656224 [TBL] [Abstract][Full Text] [Related]
5. MicroRNA‑200a suppresses migration and invasion and enhances the radiosensitivity of NSCLC cells by inhibiting the HGF/c‑Met signaling pathway. Du M; Wang J; Chen H; Wang S; Chen L; Xu Y; Su F; Lu X Oncol Rep; 2019 Mar; 41(3):1497-1508. PubMed ID: 30569179 [TBL] [Abstract][Full Text] [Related]
6. MicroRNA‑485 targets MACC1 and inhibits cervical cancer cell proliferation and invasion. Wang S; Zhang Y; Yuan S; Ji X Mol Med Rep; 2018 Aug; 18(2):2407-2416. PubMed ID: 29916552 [TBL] [Abstract][Full Text] [Related]
7. Co-overexpression of Met and hepatocyte growth factor promotes systemic metastasis in NCI-H460 non-small cell lung carcinoma cells. Navab R; Liu J; Seiden-Long I; Shih W; Li M; Bandarchi B; Chen Y; Lau D; Zu YF; Cescon D; Zhu CQ; Organ S; Ibrahimov E; Ohanessian D; Tsao MS Neoplasia; 2009 Dec; 11(12):1292-300. PubMed ID: 20019837 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of tumor growth and metastasis in non-small cell lung cancer by LY2801653, an inhibitor of several oncokinases, including MET. Wu W; Bi C; Credille KM; Manro JR; Peek VL; Donoho GP; Yan L; Wijsman JA; Yan SB; Walgren RA Clin Cancer Res; 2013 Oct; 19(20):5699-710. PubMed ID: 23989980 [TBL] [Abstract][Full Text] [Related]
9. [Prognostic value of MACC1 and c-met expressions in non-small cell lung cancer]. Hu X; Fu X; Wen S; Zou X; Liu Y Zhongguo Fei Ai Za Zhi; 2012 Jul; 15(7):399-403. PubMed ID: 22814258 [TBL] [Abstract][Full Text] [Related]
10. Endostar regulates EMT, migration and invasion of lung cancer cells through the HGF-Met pathway. Shen Y; Chen Q; Li L Mol Cell Probes; 2019 Jun; 45():57-64. PubMed ID: 31096000 [TBL] [Abstract][Full Text] [Related]
11. YB-1 regulates tumor growth by promoting MACC1/c-Met pathway in human lung adenocarcinoma. Guo T; Zhao S; Wang P; Xue X; Zhang Y; Yang M; Li N; Li Z; Xu L; Jiang L; Zhao L; Ma PC; Rosell R; Li J; Gu C Oncotarget; 2017 Jul; 8(29):48110-48125. PubMed ID: 28624808 [TBL] [Abstract][Full Text] [Related]
12. Targeting H19 by lentivirus-mediated RNA interference increases A549 cell migration and invasion. Wang L; Sun Y; Yi J; Wang X; Liang J; Pan Z; Li L; Jiang G Exp Lung Res; 2016 Sep; 42(7):346-353. PubMed ID: 27607135 [TBL] [Abstract][Full Text] [Related]
13. Long Noncoding RNA FGD5-AS1 Knockdown Decrease Viability, Migration, and Invasion of Non-Small Cell Lung Cancer (NSCLC) Cells by Regulating the MicroRNA-944/MACC1 Axis. Lv J; Li Q; Ma R; Wang Z; Yu Y; Liu H; Miao Y; Jiang S Technol Cancer Res Treat; 2021; 20():1533033821990090. PubMed ID: 33550920 [TBL] [Abstract][Full Text] [Related]
14. Gemcitabine inhibits the micrometastasis of non-small cell lung cancer by targeting the EpCAM-positive circulating tumor cells via the HGF/cMET pathway. Liao ZJ; Guo YH; Zhao Z; Yao JT; Xu R; Nan KJ Int J Oncol; 2014 Aug; 45(2):651-8. PubMed ID: 24867356 [TBL] [Abstract][Full Text] [Related]
15. Shikonin Inhibited Migration and Invasion of Human Lung Cancer Cells via Suppression of c-Met-Mediated Epithelial-to-Mesenchymal Transition. Hsieh YS; Liao CH; Chen WS; Pai JT; Weng MS J Cell Biochem; 2017 Dec; 118(12):4639-4651. PubMed ID: 28485480 [TBL] [Abstract][Full Text] [Related]
16. MicroRNA-198 inhibition of HGF/c-MET signaling pathway overcomes resistance to radiotherapy and induces apoptosis in human non-small-cell lung cancer. Zhu L; Xue F; Xu X; Xu J; Hu S; Liu S; Cui Y; Gao C J Cell Biochem; 2018 Sep; 119(9):7873-7886. PubMed ID: 29943841 [TBL] [Abstract][Full Text] [Related]
17. Combining onartuzumab with erlotinib inhibits growth of non-small cell lung cancer with activating EGFR mutations and HGF overexpression. Sano Y; Hashimoto E; Nakatani N; Abe M; Satoh Y; Sakata K; Fujii T; Fujimoto-Ouchi K; Sugimoto M; Nagahashi S; Aoki M; Motegi H; Sasaki E; Yatabe Y Mol Cancer Ther; 2015 Feb; 14(2):533-41. PubMed ID: 25522765 [TBL] [Abstract][Full Text] [Related]
18. AXL and MET receptor tyrosine kinases are essential for lung cancer metastasis. Choi YJ; Kim JH; Rho JK; Kim JS; Choi CM; Kim WS; Son J; Lee JC Oncol Rep; 2017 Apr; 37(4):2201-2208. PubMed ID: 28260071 [TBL] [Abstract][Full Text] [Related]
19. Metastasis-associated in colon cancer-1 promotes vasculogenic mimicry in gastric cancer by upregulating TWIST1/2. Wang L; Lin L; Chen X; Sun L; Liao Y; Huang N; Liao W Oncotarget; 2015 May; 6(13):11492-506. PubMed ID: 25895023 [TBL] [Abstract][Full Text] [Related]
20. MicroRNA-338-3p suppresses ovarian cancer cells growth and metastasis: implication of Wnt/catenin beta and MEK/ERK signaling pathways. Zhang R; Shi H; Ren F; Feng W; Cao Y; Li G; Liu Z; Ji P; Zhang M J Exp Clin Cancer Res; 2019 Dec; 38(1):494. PubMed ID: 31842953 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]